Total revenue of $14.5 million and diluted earnings per share of $0.10
Maintains full-year revenue guidance of $66 to $69 million and EPS guidance of $0.66 to $0.68
.
Simulations Plus, Inc. , a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the following leadership changes effective.
Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.